Epidemiology of candidemia in intensive care units

International Journal of Antimicrobial Agents

Volumn 32, Issue SUPPL. 2, 2008, Pages

  Bouza, Emilio ^a   Muñoz, Patricia ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Candidemia; Intensive care units; Invasive candidiasis; Invasive fungal infections

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CORTICOSTEROID; FLUCONAZOLE;

ABDOMINAL SURGERY; ACUTE KIDNEY FAILURE; ARTICLE; CANDIDA; CANDIDEMIA; CATHETER INFECTION; DISEASE PREDISPOSITION; FUNGAL COLONIZATION; HOSPITAL COST; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; LENGTH OF STAY; MORTALITY; NEUTROPENIA; NONHUMAN; PARENTERAL NUTRITION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANTIFUNGAL AGENTS; CANDIDIASIS; CHEMOPREVENTION; FUNGEMIA; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; RISK FACTORS;

EID: 55649087988     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(08)70006-2     Document Type: Article

References (46)

1. Richards M.J., Edwards J.R., Culver D.H., and Gaynes R.P. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21 (2000) 510-515
2. Rangel-Frausto M.S., Wiblin T., Blumberg H.M., Saiman L., Patterson J., Rinaldi M., et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29 (1999) 253-258
3. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., and Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39 (2004) 309-317
4. Nolla-Salas J., Sitges-Serra A., Leon-Gil C., Martinez-Gonzalez J., Leon-Regidor M.A., Ibanez-Lucia P., et al. Candidemia in nonneutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 23 (1997) 23-30
5. Bouza E., Perez-Molina J., and Muñoz P. Report of ESGNI01 and ESGNI02 studies. Bloodstream infections in Europe. Clin Microbiol Infect 5 Suppl 2 (1999) 2S1-212
6. Eloy O., Blanc V., Pina P., Gaudart A., Bressolle M.L., Plainvert C., et al. Epidemiology of candidemia: results of a one month French hospitals-based surveillance study in 2004 [in French]. Pathol Biol (Paris) 54 (2006) 523-530
7. Kao A.S., Brandt M.E., Pruitt W.R., Conn L.A., Perkins B.A., Stephens D.S., et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 29 (1999) 1164-1170
8. Almirante B., Rodriguez D., Park B.J., Cuenca-Estrella M., Planes A.M., Almela M., et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 43 (2005) 1829-1835
9. Asmundsdottir L.R., Erlendsdottir H., and Gottfredsson M. Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol 40 (2002) 3489-3492
10. Poikonen E., Lyytikainen O., Anttila V.J., and Ruutu P. Candidemia in Finland, 1995-1999. Emerg Infect Dis 9 (2003) 985-990
11. Rodríguez-Créixems M., Alcalá L., Muñoz P., Cercenado E., Vicente T., and Bouza E. Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006. Medicine (Baltimore) 87 (2008) 234-249
12. Diekema D.J., Messer S.A., Brueggemann A.B., Coffman S.L., Doern G.V., Herwaldt L.A., et al. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 40 (2002) 1298-1302
13. DiNubile M.J., Lupinacci R.J., Strohmaier K.M., Sable C.A., and Kartsonis N.A. Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial. J Crit Care 22 (2007) 237-244
14. Schelenz S., and Gransden W.R. Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period. Mycoses 46 (2003) 390-396
15. Trick W.E., Fridkin S.K., Edwards J.R., Hajjeh R.A., and Gaynes R.P. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 35 (2002) 627-630
16. Dimopoulos G., Ntziora F., Rachiotis G., Armaganidis A., and Falagas M.E. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg 106 (2008) 523-529
17. Bougnoux M.E., Kac G., Aegerter P., d'Enfert C., and Fagon J.Y. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 34 (2008) 292-299
18. Asmundsdottir L.R., Erlendsdottir H., Haraldsson G., Guo H., Xu J., and Gottfredsson M. Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections. Clin Infect Dis 47 (2008) e17-e24
19. Nucci M., and Anaissie E. Revisiting the source of candidemia: skin or gut?. Clin Infect Dis 33 (2001) 1959-1967
20. Richet H., Roux P., Des Champs C., Esnault Y., and Andremont A. Candidemia in French hospitals: incidence rates and characteristics. Clin Microbiol Infect 8 (2002) 405-412
21. Pfaller M.A., Jones R.N., Messer S.A., Edmond M.B., and Wenzel R.P. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. Diagn Microbiol Infect Dis 30 (1998) 121-129
22. Blumberg H.M., Jarvis W.R., Soucie J.M., Edwards J.E., Patterson J.E., Pfaller M.A., et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33 (2001) 177-186
23. Bliss J.M., Basavegowda K.P., Watson W.J., Sheikh A.U., and Ryan R.M. Vertical and horizontal transmission of Candida albicans in very low birth weight infants using DNA fingerprinting techniques. Pediatr Infect Dis J 27 (2008) 231-235
24. Davis S.L., Vazquez J.A., and McKinnon P.S. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Ann Pharmacother 41 (2007) 568-573
25. Passos X.S., Costa C.R., Araujo C.R., Nascimento E.S., e Souza L.K., Fernandes Ode F., et al. Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital. Mycopathologia 163 (2007) 145-151
26. Shorr A.F., Lazarus D.R., Sherner J.H., Jackson W.L., Morrel M., Fraser V.J., et al. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia. Crit Care Med 35 (2007) 1077-1083
27. Bassetti M., Righi E., Costa A., Fasce R., Molinari M.P., Rosso R., et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6 (2006) 21
28. Chow J.K., Golan Y., Ruthazer R., Karchmer A.W., Carmeli Y., Lichtenberg D.A., et al. Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med 36 (2008) 1993-1998
29. Chow J.K., Golan Y., Ruthazer R., Karchmer A.W., Carmeli Y., Lichtenberg D., et al. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 46 (2008) 1206-1213
30. Ruan S.Y., Lee L.N., Jerng J.S., Yu C.J., and Hsueh P.R. Candida glabrata fungaemia in intensive care units. Clin Microbiol Infect 14 (2008) 136-140
31. Wey S.B., Mori M., Pfaller M.A., Woolson R.F., and Wenzel R.P. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 149 (1989) 2349-2353
32. Singhi S., Rao D.S., and Chakrabarti A. Candida colonization and candidemia in a pediatric intensive care unit. Pediatr Crit Care Med 9 (2008) 91-95
33. Bonavina L., Incarbone R., Reitano M., Tortorano A., Viviani M., and Peracchia A. Candida colonization in patients with esophageal disease: a prospective clinical study. Dis Esophagus 16 (2003) 70-72
34. Saiman L., Ludington E., Dawson J.D., Patterson J.E., Rangel-Frausto S., Wiblin R.T., et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 20 (2001) 1119-1124
35. Magill S.S., Swoboda S.M., Johnson E.A., Merz W.G., Pelz R.K., Lipsett P.A., et al. The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. Diagn Microbiol Infect Dis 55 (2006) 293-301
36. Leon C., Ruiz-Santana S., Saavedra P., Almirante B., Nolla-Salas J., Alvarez-Lerma F., et al. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34 (2006) 730-737
37. Olaechea P.M., Palomar M., Leon-Gil C., Alvarez-Lerma F., Jorda R., Nolla-Salas J., et al. Economic impact of Candida colonization and Candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis 23 (2004) 323-330
38. Ostrosky-Zeichner L., Sable C., Sobel J., Alexander B.D., Donowitz G., Kan V., et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 26 (2007) 271-276
39. Filioti J., Spiroglou K., Panteliadis C.P., and Roilides E. Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome. Intensive Care Med 33 (2007) 1272-1283
40. Fridkin S.K., Kaufman D., Edwards J.R., Shetty S., and Horan T. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics 117 (2006) 1680-1687
41. Reissa E., Lasker B.A., Iqbal N.J., James M.J., and Arthington-Skaggs B.A. Molecular epidemiology of Candida parapsilosis sepsis from outbreak investigations in neonatal intensive care units. Infect Genet Evol 8 (2008) 103-109
42. Tiraboschi I.N., Carnovale S., Benetucci A., Fernandez N., Kurlat I., Foccoli M., et al. Candida albicans outbreak in a neonatal intensive care unit [in Spanish]. Rev Iberoam Micol 24 (2007) 263-267
43. Rodriguez D., Almirante B., Park B.J., Cuenca-Estrella M., Planes A.M., Sanchez F., et al. Candidemia in neonatal intensive care units: Barcelona, Spain. Pediatr Infect Dis J 25 (2006) 224-229
44. Garcia-San Miguel L., Cobo J., Martos I., Otheo E., Muriel A., Pintado V., et al. Risk factors for candidemia in pediatric patients with congenital heart disease. Infect Control Hosp Epidemiol 27 (2006) 576-580
45. Rentz A.M., Halpern M.T., and Bowden R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 27 (1998) 781-788
46. Smith P.B., Morgan J., Benjamin J.D., Fridkin S.K., Sanza L.T., Harrison L.H., et al. Excess costs of hospital care associated with neonatal candidemia. Pediatr Infect Dis J 26 (2007) 197-200